Close Menu

Prompted by a poor outlook in the European drug sector, Baird analyst Larry Neibor last week downgraded Waters' stock after the company cut its first-quarter revenue and earnings projections — and then promptly downgraded his entire analytical instruments sector, which includes BioCommerce Week Index members Applied Biosystems, Bruker BioSciences, Molecular Devices, PerkinElmer, Thermo Electron, and Waters

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.